Meanwhile, functional assays proved that shRELT could inhibit the migration ability (Figures 2M-O) and invasion ability (Figure 2P) of renal cancer cells, whereas RELT overexpression promoted invasion and migration of renal cell carcinoma cells (Figure 2Q). Here, RELT is linked to renal cell carcinoma.